Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-07
2009-12-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S228200, C514S229800, C514S232800, C514S249000, C514S250000, C514S250000, C514S253020, C514S278000, C514S322000, C540S500000, C544S058200, C544S101000, C544S142000, C544S238000, C544S343000, C544S349000, C544S361000, C546S017000, C546S018000, C546S187000
Reexamination Certificate
active
07629338
ABSTRACT:
Compounds of formula I:(wherein variables A1, A2, A3, A4, m, n, J, Q, R4, Ea, Eb, Ec, R6, R7, Re, Rf, RPGand Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 6953790 (2005-10-01), Burgey et al.
patent: 7189722 (2007-03-01), Bell et al.
patent: 7192954 (2007-03-01), Bell et al.
patent: 7196079 (2007-03-01), Burgey et al.
patent: 7202251 (2007-04-01), Bell et al.
patent: 7205292 (2007-04-01), Burgey et al.
patent: 7205293 (2007-04-01), Bell et al.
patent: 7235545 (2007-06-01), Burgey et al.
patent: 7390798 (2008-06-01), Williams et al.
patent: 7452903 (2008-11-01), Burgey et al.
patent: 7476665 (2009-01-01), Burgey et al.
patent: 7491713 (2009-02-01), Burgey et al.
patent: 7534784 (2009-05-01), Burgey et al.
patent: 2006/0173046 (2006-08-01), Bell et al.
patent: 2007/0287697 (2007-12-01), Paone et al.
patent: 2008/0004304 (2008-01-01), Bell et al.
patent: 2008/0070899 (2008-03-01), Burgey et al.
patent: 2008/0090806 (2008-04-01), Paone et al.
patent: 2008/0096878 (2008-04-01), Bell et al.
patent: 2008/0113966 (2008-05-01), Burgey et al.
patent: 2008/0125413 (2008-05-01), Burgey et al.
patent: 2008/0214511 (2008-09-01), Bell et al.
patent: 2008/0261972 (2008-10-01), Paone et al.
patent: 2008/0318927 (2008-12-01), Wood et al.
patent: 2009/0054408 (2009-02-01), Bell et al.
patent: 2009/0105219 (2009-04-01), Bell et al.
patent: 2009/0105228 (2009-04-01), Williams
patent: WO 2004/082605 (2004-09-01), None
patent: WO 2004/082678 (2004-09-01), None
patent: WO 2004/083187 (2004-09-01), None
patent: WO 2006/029153 (2006-03-01), None
patent: WO 2006/031491 (2006-03-01), None
patent: WO 2006/031513 (2006-03-01), None
patent: WO 2006/031606 (2006-03-01), None
patent: WO 2006/031610 (2006-03-01), None
patent: WO 2006/031676 (2006-03-01), None
patent: WO 2006/044504 (2006-04-01), None
patent: WO 2007/016087 (2007-02-01), None
patent: WO 2007/061677 (2007-05-01), None
patent: WO 2007/061692 (2007-05-01), None
patent: WO 2007/061694 (2007-05-01), None
patent: WO 2007/061696 (2007-05-01), None
patent: WO 2007/067695 (2007-06-01), None
patent: 2008/011190 (2008-01-01), None
patent: 2008/112159 (2008-09-01), None
patent: 2008/127584 (2008-10-01), None
patent: 2008/130512 (2008-10-01), None
PCT International Search Report and PCT Written Opinion of the International Searching Authority for PCT International Application No. PCT/US2007/010953.
PCT International Search Report and PCT Written Opinion of the International Searching Authority for PCT International Application No. PCT/US2007/010952.
Copending U.S. Appl. No. 12/085,057, U.S. National Stage Entry of PCT/US2006/044088, filed Nov. 14, publshed as WO 2007/061677.
Copending U.S. Appl. No. 12/085,005, U.S. National Stage Entry of PCT/US2006/044194, filed Nov. 14, 2006, published as WO 2007/061695.
Copending U.S. Appl. No. 12/085,008, U.S. National Stage Entry of PCT/US2006/044190, filed Nov. 14, 2006, published as WO 2007/061694.
Copending U.S. Appl. No. 12/084,917, U.S. National Stage Entry of PCT/US2006/044086, filed Nov. 14, 2006, published as WO 2007/061676.
Copending U.S. Appl. No. 11/662,702, U.S. National Stage Entry of PCT/US2005/032288, filed Sep. 9, 2005, published as WO 2006/031676.
Copending U.S. Appl. No. 12/085,131, U.S. National Stage Entry of PCT/US2006/044212, filed Nov. 14, 2006, published as WO 2007/061696.
Copending U.S. Appl. No. 12/517,674, U.S. National Stage Entry of PCT/US2007/024913, filed Dec. 5, 2007, published as WO 2008/073251.
Copending U.S. Appl. No. 12/520,132, U.S. National Stage Entry of PCT/US2007/025690, filed Dec. 14, 2007, published as WO 2008/085317.
Copending U.S. Appl. No. 12/417,911, filed Apr. 3, 2009.
Bell, et al., Bioorganic & Medicinal Chemistry Letters (2006), 16(24), 6165-6169.
Bell Ian M.
Gallicchio Steven N.
Selnick Harold G.
Stump Craig A.
Wood Michael R.
Kifle Bruck
Merck & Co. , Inc.
Provatin William
Yuro Raynard
LandOfFree
Substituted monocyclic CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted monocyclic CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted monocyclic CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4075141